Predictive Oncology elects Raymond F. Vennare to Board of Directors

Axe Compute Inc.

Vennare appointed as Class III Director, term expires at 2021 annual meeting.
He fills vacancy created by resignation of Richard Gabriel in May 2021.
Vennare brings 30+ years biotech experience; currently CEO of Cvergenx, Inc.
Awarded 5,000 restricted shares from Amended 2012 Stock Incentive Plan.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Raymond F. Vennare

Director

AGPU · Axe Compute Inc.

Effective: 2021-09-13
Filed: September 15, 2021, 7:59 PM ET

Effective September 13, 2021, the Board of Directors (“Board”) of Predictive Oncology Inc. (the “Company”) elected Raymond F. Vennare to the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Raymond F. Vennare was elected as Director at Axe Compute Inc..

Action: elected
Role: Director

Exact text from the filing

Effective September 13, 2021, the Board of Directors (“Board”) of Predictive Oncology Inc. (the “Company”) elected Raymond F. Vennare to the Board.

View on SEC.gov

Axe Compute Inc. filing history →

Source: SEC EDGAR

accession 0001171843-21-006490

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.